HIV cell dysfunction discovery sheds light on how virus works

April 7, 2018, University of Texas at Austin
HIV infection impacts the normal function of follicular T cell. Credit: Carla Shaffer / AAAS

A team of chemical and biomedical engineers from the Cockrell School of Engineering at The University of Texas at Austin, in collaboration with researchers from the University of Pennsylvania, have discovered that HIV-infected patients experience a dysfunction in a certain type of immune cell: the follicular helper T (Tfh) cell.

In a paper published today in Science Immunology, the authors outline how, through combining a sophisticated sequencing technique with a mass cytometry method (the measurement of cell characteristics), they discovered the Tfh cell dysfunction.

According to the latest figures from the World Health Organization, about 40 million people worldwide are living with HIV/AIDS. In the U.S., about 1 million are living with the virus, and 1 in 7 of those infected don't know it. Overall, the number of recorded cases has been in steady decline—thanks to medical advances and greater public awareness. Still, major information gaps remain in our understanding of the fundamental nature of HIV, making every new insight important.

The UT Austin research team's finding is significant because the Tfh —which are present in greater numbers in HIV-infected patients than in healthy individuals— typically help fight off infection by communicating with other immune-supporting cells in the lymph nodes (the immune system's command center) about an impending viral attack. The researchers found that the Tfh cells present in those infected with HIV are not playing their usual part to defend against .

An interview with Dr. Laura Su, Jenny (Ning) Jiang and Ben Wendel. Credit: Juwon Song / AAAS

Led by UT Austin assistant professor Jenny Jiang in the Department of Biomedical Engineering, the research team combined techniques and approaches developed by Jiang and Laura Su, assistant professor of medicine in Penn's Perelman School of Medicine. Together, these technologies allowed the team to comprehensively profile T cells in the lymph node glands of HIV patients.

"These types of cells play a critical role during viral infections of any kind," Jiang said. "They communicate with other immune cells and provide instructions to B cells, for example, to produce virus-neutralizing antibodies that not only kill it off but also help prevent future infections."

Although the CD4+ T cell is notoriously depleted in patients infected with HIV, the population of Tfh cells is actually more elevated in the lymph nodes of those infected with HIV than it is in healthy individuals. This paradox is what makes further analysis of Tfh cell behavior by anyone studying HIV so vital.

Based on their central role in generating protective antibodies, it would be intuitive to assume that the increased presence of Tfh cells should result in greater resistance to infection. However, the researchers found this not to be the case, suggesting that Tfh cells in HIV patients are ineffective at sending signals to B cells to request help to fight off the .

"We believe Tfh cells behave differently when fighting chronic infections like HIV versus when fighting off acute infections like the common cold, potentially making them an easy target for HIV," Jiang said. "Our next step is to determine why the Tfh cell dysfunction occurs in HIV-infected , moving us one step closer to better understanding the virus."

Explore further: Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

More information: Ben S. Wendel et al. The receptor repertoire and functional profile of follicular T cells in HIV-infected lymph nodes, Science Immunology (2018). DOI: 10.1126/sciimmunol.aan8884

Related Stories

Regulatory T cells harbor HIV/SIV virus during antiviral drug treatment

October 17, 2017
Scientists at Yerkes National Primate Research Center, Emory University have identified an additional part of the HIV reservoir, immune cells that survive and harbor the virus despite long-term treatment with antiviral drugs.

Intestinal worms boost immune system in a surprising way

May 5, 2016
In order to fight invading pathogens, the immune system uses "outposts" throughout the body, called lymph nodes. These are small, centimeter-long organs that filter fluids, get rid of waste materials, and trap pathogens, ...

New target to fight HIV infection identified

October 1, 2013
A mutant of an immune cell protein called ADAP (adhesion and degranulation-promoting adaptor protein) is able to block infection by HIV-1 (human immunodeficiency virus 1), new University of Cambridge research reveals. The ...

High viral load in HIV-infected individuals underlies innate immune cell dysfunction

March 17, 2016
Individuals infected with HIV exhibit both severe immune deficiency and aberrant inflammation, resulting in susceptibility to secondary infection as the disease progresses. HIV-associated deficiencies in adaptive immune responses ...

Candida-specific helper T cells are preferential and early targets of HIV

June 9, 2016
Candida yeasts normally live on human skin and mucous membranes without causing disease. In individuals with a weakened immune system, however, they are a major cause of opportunistic infections. A study published on June ...

New therapeutic target against persistent viral infections

January 11, 2017
Life is a question of balance, and the body is no exception. Expression levels of certain proteins can affect the immune system's ability to neutralize a virus. Type I interferons (IFN-I) are cytokines that were previously ...

Recommended for you

A Trojan Horse delivery for treating a rare, potentially deadly, blood-clotting disorder

September 21, 2018
In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP. The researchers deliver this therapeutic ...

Study shows surprise low-level ozone impact on asthma patients

September 21, 2018
A new study led by UNC School of Medicine researchers indicates that ozone has a greater impact on asthma patients than previously thought. The study, published in the Journal of Allergy and Clinical Immunology, recruited ...

Cancer immunotherapy might benefit from previously overlooked immune players

September 20, 2018
Cancer immunotherapy—efforts to boost a patient's own immune system, allowing it to better fight cancer cells on its own—has shown great promise for some previously intractable cancers. Yet immunotherapy doesn't work ...

Gut fungus exacerbates asthma in antibiotic-treated mice

September 20, 2018
A non-pathogenic fungus can expand in the intestines of antibiotic-treated mice and enhance the severity of allergic airways disease, according to a study published September 20 in the open-access journal PLOS Pathogens by ...

Paracetamol use in infancy is linked to increased risk of asthma in some teenagers

September 17, 2018
Children who take paracetamol during their first two years of life may be at a higher risk of developing asthma by the age of 18, especially if they have a particular genetic makeup, according to new research presented at ...

Cord blood clue to respiratory diseases

September 15, 2018
New research has found children born in the last three months of the year in Melbourne may have a greater risk of developing respiratory diseases such as asthma.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.